Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Major IPOs/follow-ons in cell and gene therapy by amount raised 2020

This statistic depicts the top ten initial public offerings (IPOs) and follow-ons in the cell and gene therapy industry in 2020, by amount raised. During this year, the highest offerings were follow-on offerings with Iovance's raise of 604 million U.S. dollars, and Bluebird's raise of 575 million U.S. dollars.

Leading 10 IPOs and follow-ons in the cell and gene therapy industry worldwide in 2020, by amount raised

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2021

Region

Worldwide

Survey time period

2020

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Cell and gene therapy"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.